查看購物車
  • English
  • Japanese
亞太地區基因改造動物模型市場：按技術、動物類型、應用、最終用戶和國家分類的分析和預測（2025-2035 年）
市場調查報告書
商品編碼
2029917

亞太地區基因改造動物模型市場：按技術、動物類型、應用、最終用戶和國家分類的分析和預測（2025-2035 年）

Asia-Pacific Transgenic Animal Model Market: Focus on Technology, Animal Type, Application, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 76 Pages | 商品交期: 1-5個工作天內

價格

亞太地區的基因改造動物模型市場正在經歷顯著成長，這得益於生物技術研究的擴張、製藥業研發投入的增加以及對先進臨床前模型的需求不斷成長。

全球基因改造動物模型市場預計在2025年至2035年的預測期內將保持穩定成長，其中亞太地區將成為高成長區域。中國、日本和印度等國家憑藉強力的政府支持、不斷完善的研究基礎設施以及對基因組學和個人化醫療日益成長的關注，正在推動這一市場的成長。基因編輯技術在該地區快速普及以及產學研合作的加強，也進一步加速了市場成長。

關鍵市場統計數據
預測期 2025-2035
2025年市場規模 6.602億美元
2035年預測 16.984億美元
複合年成長率 9.91%

預計到 2035 年，亞太地區基因改造動物模型市場規模將達到 16.984 億美元，而 2025 年為 6.602 億美元，預計在 2025 年至 2035 年的預測期內，複合年成長率將達到 9.91%。

亞太地區的基因改造動物模型市場正成為該地區快速發展的生命科學和生物技術生態系統的重要組成部分。基因改造動物模型是指基因經過改造的生物體，其基因已被導入或改變，使研究人員能夠研究基因功能、疾病進展和治療反應。這些模型廣泛應用於藥物研發、毒性測試和基礎生物學研究。

在亞太地區，慢性病負擔日益加重、醫藥和生物技術領域的投資不斷成長以及研究能力的提升，正推動著對基因改造動物模型的需求。中國和日本等國家正大力投資基因組研究和基因編輯技術，而印度則正崛起成為合約研究和臨床前試驗的中心。

技術進步，特別是利用CRISPR/Cas9進行基因編輯的技術進步，顯著提高了基因改造模型建構的效率和準確性，使其更易於取得且成本更低。此外，隨著精準醫療和標靶治療的日益普及，對能夠模擬人類疾病狀態的高度特化的動物模型的需求也日益成長。

亞太地區的法規結構雖然因國家而異，但總體上正朝著支持符合倫理的研究實踐的方向發展。因此，該地區的基因改造動物模型市場呈現出快速創新、投資增加以及相關人員之間合作加強的特徵。

市場區隔:

細分 1：按技術

  • CRISPR/Cas-9
  • 顯微注射
  • 胚胎幹細胞注射
  • 其他

第二部分：動物物種

  • 囓齒動物（小鼠和大鼠）
  • 兔子
  • 豬
  • 其他

細分3：按應用

  • 藥物發現和藥物開發
  • 疾病研究
  • 基因功能研究
  • 毒性評估和安全性測試
  • 其他

細分 4：按最終用戶

  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構（CRO）

第五部分：按國家分類

  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 其他

市場趨勢、促進因素與挑戰

市場趨勢

  • CRISPR/Cas9 和先進基因編輯技術的快速傳播
  • 人們越來越關注精準醫療和標靶治療
  • 拓展腫瘤、神經系統疾病和罕見疾病的基因改造模型。
  • 擴大學術機構與生技公司之間的合作

市場促進因素

  • 藥物研發中對高效臨床前模型的需求日益成長。
  • 增加對生物技術和生命科學研究的投資
  • 亞太地區慢性病及遺傳性病患病率增加
  • 新興市場製藥和CRO產業的擴張

市場挑戰

  • 關於動物實驗和基因改造的倫理問題
  • 開發基因改造模型涉及高成本和技術複雜性。
  • 亞太地區國家缺乏標準化的法規結構
  • 重現複雜人類疾病狀態的局限性

本報告檢視了亞太地區的基因改造動物模型市場，總結了關鍵趨勢、市場影響因素、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

執行摘要

範圍和定義

第1章：亞太地區基因改造動物模型市場：產業展望

  • 市場概覽
    • 市場概覽與生態系統
  • 市場趨勢
    • 影響分析
    • 對個人化醫療的需求日益成長
  • 監理情勢
    • 亞太地區
  • 價格分析
    • 產生成本（創建新模型的成本）
    • 購置成本（購買現有型號的成本）
    • 其他額外費用
  • 技術展望
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 區域

  • 區域概況
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 威脅市場的因素
    • 市場規模及預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他

第3章：競爭標竿分析與公司概況

  • 公司簡介
    • HuidaGene

第4章：調查方法

Product Code: BHL3665SS

This report can be delivered in 2 working days.

Market Overview

The APAC transgenic animal model market is witnessing significant growth, driven by expanding biotechnology research, increasing pharmaceutical R&D investments, and rising demand for advanced preclinical models. The global transgenic animal model market is expected to grow steadily during the forecast period 2025-2035, with Asia-Pacific emerging as a high-growth region. Countries such as China, Japan, and India are leading this expansion due to strong government support, growing research infrastructure, and increasing focus on genomics and personalized medicine. The region's rapid adoption of gene-editing technologies and rising collaborations between academia and industry are further accelerating market growth.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$660.2 Million
2035 Forecast$1,698.4 Million
CAGR9.91%

The Asia-Pacific transgenic animal model market is projected to reach $1,698.4 million by 2035 from $660.2 million in 2025, growing at a CAGR of 9.91% during the forecast period 2025-2035.

Market Introduction

The APAC transgenic animal model market is becoming a key component of the region's rapidly advancing life sciences and biotechnology ecosystem. Transgenic animal models are genetically engineered organisms that carry inserted or modified genes, enabling researchers to study gene function, disease progression, and therapeutic responses. These models are widely used in drug discovery, toxicology studies, and basic biological research.

In Asia-Pacific, the demand for transgenic animal models is increasing due to the growing burden of chronic diseases, rising investments in pharmaceutical and biotechnology sectors, and the expansion of research capabilities. Countries such as China and Japan are heavily investing in genomic research and gene-editing technologies, while India is emerging as a hub for contract research and preclinical studies.

Technological advancements, particularly in CRISPR/Cas9 gene-editing, have significantly improved the efficiency and accuracy of developing transgenic models, making them more accessible and cost-effective. Additionally, the increasing focus on precision medicine and targeted therapies is driving the need for highly specialized animal models that can replicate human disease conditions.

Regulatory frameworks across APAC are evolving to support ethical research practices, although variations exist across countries. As a result, the APAC transgenic animal model market is characterized by rapid innovation, growing investments, and increasing collaboration among stakeholders.

Market Segmentation:

Segmentation 1: By Technology

  • CRISPR/CAS-9
  • Microinjections
  • Embryonic Stem Cell Injections
  • Others

Segmentation 2: By Animal Type

  • Rodent (Mice & Rats)
  • Rabbits
  • Pigs
  • Others

Segmentation 3: By Application

  • Drug Discovery and Development
  • Disease Research
  • Gene Function Studies
  • Toxicology and Safety Testing
  • Others

Segmentation 4: By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Segmentation 5: by Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

Market Trends, Drivers, and Challenges

Market Trends

  • Rapid adoption of CRISPR/Cas9 and advanced gene-editing technologies
  • Increasing focus on precision medicine and targeted therapies
  • Expansion of transgenic models for oncology, neurology, and rare diseases
  • Growing collaborations between academic institutions and biotech companies

Market Drivers

  • Rising demand for efficient preclinical models in drug development
  • Increasing investments in biotechnology and life sciences research
  • Growing prevalence of chronic and genetic diseases in APAC
  • Expanding pharmaceutical and CRO industries in emerging economies

Market Challenges

  • Ethical concerns related to animal testing and genetic modification
  • High cost and technical complexity of developing transgenic models
  • Lack of standardized regulatory frameworks across APAC countries
  • Limitations in replicating complex human disease conditions

How This Report Can Add Value?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in transgenic animal model, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new transgenic animal model products.

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Table of Contents

Executive Summary

Scope and Definition

1 Asia-Pacific Transgenic Animal Model Market: Industry Outlook

  • 1.1 Market Overview
    • 1.1.1 Market Overview and Ecosystem
  • 1.2 Market Trends
    • 1.2.1 Impact Analysis
    • 1.2.2 Rising Demand for Personalized Medicine
  • 1.3 Regulatory Landscape
    • 1.3.1 Asia-Pacific
      • 1.3.1.1 China
      • 1.3.1.2 Japan
  • 1.4 Pricing Analysis
    • 1.4.1 Generation Costs (Creating New Models)
    • 1.4.2 Acquisition Costs (Purchasing Existing Models)
    • 1.4.3 Additional Costs
  • 1.5 Technology Landscape
  • 1.6 Market Dynamics
    • 1.6.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.6.2 Market Drivers
      • 1.6.2.1 Growing Number of Pharmaceutical Research and Drug Development Activities
      • 1.6.2.2 Technological Advancements in Genetic Engineering
      • 1.6.2.3 Increasing Demand for Advanced Disease Models for Drug Discovery
    • 1.6.3 Market Restraints
      • 1.6.3.1 High Maintenance Cost of Animal Models
      • 1.6.3.2 Strict Regulations and Guidelines
    • 1.6.4 Market Opportunities
      • 1.6.4.1 Emergence of CRISPR as a Powerful Tool for Biomedical Research Field
      • 1.6.4.2 Increasing Demand for Disease-Specific Models

2 Region

  • 2.1 Regional Summary
  • 2.2 Asia Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Market Sizing and Forecast
      • 2.2.4.1 Asia Pacific Transgenic Animal Model Market, by Technology
      • 2.2.4.2 Asia Pacific Transgenic Animal Model Market, by Animal Type
      • 2.2.4.3 Asia Pacific Transgenic Animal Model Market, by Application
      • 2.2.4.4 Asia Pacific Transgenic Animal Model Market, by End User
      • 2.2.4.5 Asia PacificTransgenic Animal Model Market, by Country
    • 2.2.5 China
      • 2.2.5.1 Country Overview
      • 2.2.5.2 China Transgenic Animal Model Market, by Technology
      • 2.2.5.3 China Transgenic Animal Model Market, by Animal Type
      • 2.2.5.4 China Transgenic Animal Model Market, by Application
      • 2.2.5.5 China Transgenic Animal Model Market, by End User
    • 2.2.6 Japan
      • 2.2.6.1 Country Overview
      • 2.2.6.2 Japan Transgenic Animal Model Market, by Technology
      • 2.2.6.3 Japan Transgenic Animal Model Market, by Animal Type
      • 2.2.6.4 Japan Transgenic Animal Model Market, by Application
      • 2.2.6.5 Japan Transgenic Animal Model Market, by End User
    • 2.2.7 India
      • 2.2.7.1 Country Overview
      • 2.2.7.2 India Transgenic Animal Model Market, by Technology
      • 2.2.7.3 India Transgenic Animal Model Market, by Animal Type
      • 2.2.7.4 India Transgenic Animal Model Market, by Application
      • 2.2.7.5 India Transgenic Animal Model Market, by End User
    • 2.2.8 Australia
      • 2.2.8.1 Country Overview
      • 2.2.8.2 Australia Transgenic Animal Model Market, by Technology
      • 2.2.8.3 Australia Transgenic Animal Model Market, by Animal Type
      • 2.2.8.4 Australia Transgenic Animal Model Market, by Application
      • 2.2.8.5 Australia Transgenic Animal Model Market, by End User
    • 2.2.9 South Korea
      • 2.2.9.1 Country Overview
      • 2.2.9.2 South Korea Transgenic Animal Model Market, by Technology
      • 2.2.9.3 South Korea Transgenic Animal Model Market, by Animal Type
      • 2.2.9.4 South Korea Transgenic Animal Model Market, by Application
      • 2.2.9.5 South Korea Transgenic Animal Model Market, by End User
    • 2.2.10 Rest-of-the- Asia Pacific
      • 2.2.10.1 Country Overview
      • 2.2.10.2 Rest of the Asia Pacific Transgenic Animal Model Market, by Technology
      • 2.2.10.3 Rest of the Asia Pacific Transgenic Animal Model Market, by Animal Type
      • 2.2.10.4 Rest of the Asia Pacific Transgenic Animal Model Market, by Application
      • 2.2.10.5 Rest of the Asia Pacific Transgenic Animal Model Market, by End User

3 Competitive Benchmarking and Company Profiles

  • 3.1 Company Profiles
    • 3.1.1 HuidaGene
      • 3.1.1.1 Overview

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Inclusion and Exclusion
    • 4.1.4 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Transgenic Animal Model Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Transgenic Animal Model Market, 2024 and 2035
  • Figure 3: Asia-Pacific Transgenic Animal Model Market Snapshot
  • Figure 4: Transgenic Animal Model Market, $Million, 2024 and 2035
  • Figure 5: Asia-Pacific Transgenic Animal Model Market (by Technology), $Million, 2024, 2028, and 2035
  • Figure 6: Asia-Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024, 2028, and 2035
  • Figure 7: Asia-Pacific Transgenic Animal Model Market (by Application), $Million, 2024, 2028, and 2035
  • Figure 8: Asia-Pacific Transgenic Animal Model Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 9: Key Stakeholders of Transgenic Animal Model Market
  • Figure 10: Transgenic Animals: Timeline of Key Events
  • Figure 11: Role of Humanized Mouse Models in Development of New Precision and Personalized Medicine Strategies
  • Figure 12: Evolution of Transgenic Technologies
  • Figure 13: Drug Development Pipeline, 2019 and 2024
  • Figure 14: Major Technical Advances in Genome Editing and Delivery in Mice and Rats from 1980s to 2020s
  • Figure 15: Asia Pacific Transgenic Animal Model Market, $Million, 2024-2035
  • Figure 16: Inclusion and Exclusion Criteria for Transgenic Animal Model Market
  • Figure 17: Data Triangulation
  • Figure 18: Top-Down and Bottom-Up Approach
  • Figure 19: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Cost of Generating New Transgenic Animals
  • Table 3: Cost of Purchasing Existing Models
  • Table 4: Additional Costs
  • Table 5: Transgenic Animal Model Market (by Region), $Million, 2024-2035
  • Table 6: Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 7: Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 8: Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 9: Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 10: Asia Pacific Transgenic Animal Model Market (by Country), $Million, 2024-2035
  • Table 11: China Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 12: China Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 13: China Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 14: China Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 15: Japan Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 16: Japan Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 17: Japan Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 18: Japan Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 19: India Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 20: India Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 21: India Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 22: India Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 23: Australia Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 24: Australia Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 25: Australia Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 26: Australia Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 27: South Korea Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 28: South Korea Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 29: South Korea Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 30: South Korea Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 31: Rest of the Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 32: Rest of the Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 33: Rest of the Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 34: Rest of the Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035